Premium
Development of evidence‐based consensus on critical issues in the management of patients with vitiligo: A modified Delphi study
Author(s) -
Bae Jung Min,
Jeong KiHeon,
Choi Chong Won,
Park Ji Hun,
Lee Hee Jung,
Kim Hee Jung,
Lee Sang Hoon,
Oh Sang Ho,
Shin Jeonghyun,
Kang Hee Young,
Lee Weon Ju,
Ju Hyun Jeong,
Kim Dong Hyun,
Chang Sung Eun,
Lee Dong Youn,
Kim You Chan,
Choi Gwang Seong,
Kim KiHo,
Kim Tae Heung,
Lee Seung Chul,
Lee AiYoung,
Hann SeungKyung,
Lee MuHyoung,
Park Chul Jong
Publication year - 2021
Publication title -
photodermatology, photoimmunology and photomedicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.736
H-Index - 60
eISSN - 1600-0781
pISSN - 0905-4383
DOI - 10.1111/phpp.12598
Subject(s) - vitiligo , medicine , delphi method , delphi , psychological intervention , dermatology , psychology , psychiatry , computer science , artificial intelligence , operating system
Background/purpose Vitiligo remains a major challenge in dermatology. However, much of the treatment remains unclear, because little evidence is available. We sought to answer some critical questions pertaining to management of vitiligo patients. Methods A modified Delphi process among 31 vitiligo experts was conducted. A total of 12 clinical vitiligo treatment questions without clear answers were collected via a vote. To address each question, two members performed systematic literature reviews and prepared draft statements along with the levels of evidence and strength of recommendation. After reviewing the draft, all expressed their extent of agreement from 1 (strong disagreement) to 9 (strong agreement) for each item. The drafts were revised to reflect suggested comments. Discussion continued until all members agreed with the ultimate decision. Results The consensus process was completed after five rounds. We identified the best answers to 12 key questions, including issues on long‐term phototherapy, systemic and topical corticosteroids, topical calcineurin inhibitors, immunosuppressants, excimer laser treatment, and surgical interventions. Conclusion This consensus would complement current guidelines and aid both physician and patient decision‐making in the treatment of vitiligo.